OBJECTIVES: Argon plasma coagulation (APC), performed as an outpatient procedure, is used to treat severe allergic rhinitis (AR) that is unresponsive to drug therapy. The purpose of this study was to determine the therapeutic effects of APC on patients with perennial AR (PAR) or seasonal AR (pollinosis), and to confirm complications after APC. METHODS: We performed bilateral APC under local anesthesia on 387 patients with PAR or Japanese cedar pollinosis at our clinic between November 2007 and August 2012. Postoperative changes in nasal symptoms including sneezing, nasal discharge and nasal obstruction, and intranasal findings were evaluated using a visual analogue scale (VAS) and the nasal grading score respectively, according to the Practical Guidelines for the Management of Allergic Rhinitis in Japan in 2013. RESULTS: In patients with PAR, the mean VAS scores of nasal symptoms improved in 6 months after APC. The severity of RAST scores to house dust, cauterized level, and nasal septum deviation did not show significant influence on the improvement of nasal obstruction after APC. In patients with pollinosis, the mean VAS score of nasal symptoms showed an improvement of 40-60% for one season after APC. Our data also indicated that the most proper time for APC in seasonal AR was for 2 months before the pollen dispersion. As regards to major postoperative complications, atrophy of the inferior turbinate (8%) and epistaxis (3%) were observed. The patients more than 40 years old and/or with RAST scores less than class 3 to house dust were found as significant high risk factors of inferior turbinate atrophy after APC. CONCLUSIONS: These results indicated that the APC is a useful treatment for patients with AR.